France issues a challenge to the Commission on parallel trade
This article was originally published in Scrip
Executive Summary
If the European Court of Justice’s latest decision on parallel trade was aimed at bringing matters to a head, then it has certainly worked: France has taken the bait. In a dossier published late last month, the Strategic Council of the Healthcare Industries announced proposals to “improve the monitoring of medicines sold for export purposes”.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
Need a specific report? 1000+ reports available
Buy Reports